Entire Sector of Drugs & Pharmaceuticals freed from industrial licensing
In a move meant to boost the growth of
Indian biotechnology sector, union commerce ministry
has notified the deletion of all items relating to drugs
and pharmaceuticals from industrial license requirement.
The changes would free the manufacturers of bulk drugs
produced by the use of recombinant DNA technology, bulk
drugs requiring in-vivo use of nucleic acids, and specific
cell/tissue targeted formulations from the clutches
of industrial licensing. The notification issued by
the Department of Industrial Policy and Promotion states
that the Item No 16 in Schedule II of the Principal
notification - S.O 477 (E) which relates to drugs and
pharmaceuticals and the entries related shall be omitted.
October 19, 2005